Literature DB >> 21516419

Cell migration and invasion assays.

Karwan A Moutasim1, Maria L Nystrom, Gareth J Thomas.   

Abstract

A number of in vitro assays have been developed to study tumor cell motility. Historically, assays have been mainly monocellular, where carcinoma cells are studied in isolation. Scratch assays can be used to study the collective and directional movement of populations of cells, whereas two chamber assays lend themselves to the analysis of chemotactic/haptotactic migration and cell invasion. However, an inherent disadvantage of these assays is that they grossly oversimplify the complex process of invasion, lacking the tumor structural architecture and stromal components. Organotypic assays, where tumor cells are grown at an air/liquid interface on gels populated with stromal cells, are a more physiologically relevant method for studying 3-dimensional tumor invasion.

Entities:  

Mesh:

Year:  2011        PMID: 21516419     DOI: 10.1007/978-1-61779-080-5_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Microfluidic analysis of extracellular matrix-bFGF crosstalk on primary human myoblast chemoproliferation, chemokinesis, and chemotaxis.

Authors:  Meghaan M Ferreira; Ruby E Dewi; Sarah C Heilshorn
Journal:  Integr Biol (Camb)       Date:  2015-04-24       Impact factor: 2.192

2.  The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts.

Authors:  Tianyi Liu; Linli Zhou; Kun Yang; Kentaro Iwasawa; Ana Luisa Kadekaro; Takanori Takebe; Thomas Andl; Yuhang Zhang
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

3.  Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells.

Authors:  Yoshihiro Watanabe; Taku Murata; Kasumi Shimizu; Hiroshi Morita; Madoka Inui; Toshiro Tagawa
Journal:  Exp Ther Med       Date:  2012-05-23       Impact factor: 2.447

4.  RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.

Authors:  Dan Shan; Jason Li; Ping Cai; Preethy Prasad; Franky Liu; Andrew Michael Rauth; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

5.  A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.

Authors:  Benelita T Elie; Yuriy Pechenyy; Fathema Uddin; María Contel
Journal:  J Biol Inorg Chem       Date:  2018-03-05       Impact factor: 3.358

6.  Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts.

Authors:  Benjamin P Sharpe; Annette Hayden; Antigoni Manousopoulou; Andrew Cowie; Robert C Walker; Jack Harrington; Fereshteh Izadi; Stella P Breininger; Jane Gibson; Oliver Pickering; Eleanor Jaynes; Ewan Kyle; John H Saunders; Simon L Parsons; Alison A Ritchie; Philip A Clarke; Pamela Collier; Nigel P Mongan; David O Bates; Kiren Yacqub-Usman; Spiros D Garbis; Zoë Walters; Matthew Rose-Zerilli; Anna M Grabowska; Timothy J Underwood
Journal:  Cell Rep Med       Date:  2022-06-21

7.  Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin.

Authors:  Diana Tavares-Valente; Fátima Baltazar; Roxana Moreira; Odília Queirós
Journal:  J Bioenerg Biomembr       Date:  2013-06-30       Impact factor: 2.945

8.  Contribution of in vitro comparison of colorectal carcinoma cells from primary and metastatic lesions to elucidation of mechanisms of tumor progression and response to anticancer therapy.

Authors:  Lukáš Krbal; Veronika Hanušová; Jiří Soukup; Stanislav John; Petra Matoušková; Aleš Ryška
Journal:  Tumour Biol       Date:  2016-01-21

9.  A Tubing-Free Microfluidic Wound Healing Assay Enabling the Quantification of Vascular Smooth Muscle Cell Migration.

Authors:  Yuanchen Wei; Feng Chen; Tao Zhang; Deyong Chen; Xin Jia; Junbo Wang; Wei Guo; Jian Chen
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

10.  Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling.

Authors:  Weidong Li; Qian Wang; Qiaozhen Su; Dandan Ma; Chang An; Lei Ma; Hongfeng Liang
Journal:  Mol Cells       Date:  2014-05-08       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.